The Latin America, Middle East and Africa Smart Inhalers Market would witness market growth of 30.5% CAGR during the forecast period (2021-2027).
Smart inhalers, based on the time of the last dose, notify patients of missed or repeated doses and remind them to take their doses on time, simply and automatically. These reminders can be sent to the patient wherever he or she is. These gadgets can help ease the stress of remembering to take prescriptions on time, especially if there are a lot of medications to remember. They can aid in the improvement of breathing techniques and efficacy. Finally, they keep track of symptoms for both patients and doctors to see how, where, and when symptoms worsen, as well as monitor the usage of the rescue inhaler for quick relief.
The crucial issue here is that a patient's poor control be recognized, as evidenced by the requirement of rescue or reliever medication more than twice a year. This highlights the need to scale up the preventive plan for such a person, such as retraining the patient to correctly use the inhaler or looking for trigger factors such as a new pet, tobacco smoke exposure, or airborne pollution. Smart inhalers can help expand the reach of specialist health care to remote or underserved areas, albeit adherence is generally poor. At all levels, such initiatives are also cost-effective.
There is inter-and intra-regional variation in asthma prevalence in the Middle East. The prevalence was reported to be 23.6 percent in Saudi Arabia, 19.8 percent in Qatar, and 7.8 percent to 17.3 percent in different parts of Oman. Using the ISAAC questionnaire, research from the UAE's Al in region found a prevalence of 13 percent, while another using the ECRHS questionnaire found a range of 8 to 10% across the UAE. Asthma has a detrimental effect on people's quality of life and contributes to the financial burden on individuals and the healthcare system. The cost of asthma medicine isn't the only factor to consider. Outpatient consultations, inpatient stays for illness control and missed work or school are all examples of hospital visits that incur additional costs. According to the AIRGNE data, asthma causes sickness absenteeism in 30 percent of adults and 52 percent of children each year. The adoption of smart inhalers in the region can empower
The Brazil market dominated the LAMEA Smart Inhalers Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $7,116.9 Thousands by 2027. The Argentina market is anticipated to grow at a CAGR of 31.2% during (2021 - 2027). Additionally, The UAE market would display a CAGR of 30.1% during (2021 - 2027).
Based on Product, the market is segmented into Metered Dose Inhalers (MDI's), and Dry Powdered Inhalers (DPIs). Based on Disease Indication, the market is segmented into Asthma, and Chronic Obstructive Pulmonary Disease (COPD). Based on Distribution Channel, the market is segmented into Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Smart Inhalers Market is Predict to reach $414.4 Million by 2027, at a CAGR of 24.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Adherium Limited, Aptar Group Inc. (Cohero Health Inc.), AstraZeneca, Inc., Cognita Labs, LLC, GlaxoSmithKline Plc, Novartis AG, OPKO Health, Inc., Philip Morris International, Inc. (Vectura Group Plc), Resmed, Inc. (Propeller Health), and Teva Pharmaceutical Industries Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Metered Dose Inhalers (MDI's)
- Dry Powdered Inhalers (DPIs)
By Disease Indication
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Adherium Limited
- Aptar Group Inc. (Cohero Health Inc.)
- AstraZeneca, Inc.
- Cognita Labs, LLC
- GlaxoSmithKline Plc
- Novartis AG
- OPKO Health, Inc.
- Philip Morris International, Inc. (Vectura Group Plc)
- Resmed, Inc. (Propeller Health)
- Teva Pharmaceutical Industries Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Smart Inhalers Market, by Product
1.4.2 LAMEA Smart Inhalers Market, by Disease Indication
1.4.3 LAMEA Smart Inhalers Market, by Distribution Channel
1.4.4 LAMEA Smart Inhalers Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
Chapter 4. LAMEA Smart Inhalers Market by Product
4.1 LAMEA Metered Dose Inhalers (MDI's) Market by Country
4.2 LAMEA Dry Powdered Inhalers (DPIs) Market by Country
Chapter 5. LAMEA Smart Inhalers Market by Disease Indication
5.1 LAMEA Asthma Market by Country
5.2 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Market by Country
Chapter 6. LAMEA Smart Inhalers Market by Distribution Channel
6.1 LAMEA Hospitals Pharmacies Market by Country
6.2 LAMEA Retail Pharmacies Market by Country
6.3 LAMEA Online Pharmacies Market by Country
Chapter 7. LAMEA Smart Inhalers Market by Country
7.1 Brazil Smart Inhalers Market
7.1.1 Brazil Smart Inhalers Market by Product
7.1.2 Brazil Smart Inhalers Market by Disease Indication
7.1.3 Brazil Smart Inhalers Market by Distribution Channel
7.2 Argentina Smart Inhalers Market
7.2.1 Argentina Smart Inhalers Market by Product
7.2.2 Argentina Smart Inhalers Market by Disease Indication
7.2.3 Argentina Smart Inhalers Market by Distribution Channel
7.3 UAE Smart Inhalers Market
7.3.1 UAE Smart Inhalers Market by Product
7.3.2 UAE Smart Inhalers Market by Disease Indication
7.3.3 UAE Smart Inhalers Market by Distribution Channel
7.4 Saudi Arabia Smart Inhalers Market
7.4.1 Saudi Arabia Smart Inhalers Market by Product
7.4.2 Saudi Arabia Smart Inhalers Market by Disease Indication
7.4.3 Saudi Arabia Smart Inhalers Market by Distribution Channel
7.5 South Africa Smart Inhalers Market
7.5.1 South Africa Smart Inhalers Market by Product
7.5.2 South Africa Smart Inhalers Market by Disease Indication
7.5.3 South Africa Smart Inhalers Market by Distribution Channel
7.6 Nigeria Smart Inhalers Market
7.6.1 Nigeria Smart Inhalers Market by Product
7.6.2 Nigeria Smart Inhalers Market by Disease Indication
7.6.3 Nigeria Smart Inhalers Market by Distribution Channel
7.7 Rest of LAMEA Smart Inhalers Market
7.7.1 Rest of LAMEA Smart Inhalers Market by Product
7.7.2 Rest of LAMEA Smart Inhalers Market by Disease Indication
7.7.3 Rest of LAMEA Smart Inhalers Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Adherium Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Approvals and Trials:
8.2 GlaxoSmithKline PLC (GSK)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Teva Pharmaceutical Industries Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 AstraZeneca PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 OPKO Health, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.6 Aptar Group, Inc. (Cohero Health Inc.)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.7 Novartis AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Approvals and Trials:
8.8 ResMed, Inc. (Propeller Health)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Acquisition and Mergers:
8.9 Cognita Labs, LLC
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Approvals and Trials:
8.10. Vectura Group plc (Philip Morris International, Inc.)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
TABLE 1 LAMEA Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 2 LAMEA Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 3 Partnerships, Collaborations and Agreements– Smart Inhalers Market
TABLE 4 Product Launches And Product Expansions– Smart Inhalers Market
TABLE 5 Acquisition and Mergers– Smart Inhalers Market
TABLE 6 Approvals and trials- smart inhalers market
TABLE 7 LAMEA Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 8 LAMEA Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 9 LAMEA Metered Dose Inhalers (MDI's) Market by Country, 2017 - 2020, USD Thousands
TABLE 10 LAMEA Metered Dose Inhalers (MDI's) Market by Country, 2021 - 2027, USD Thousands
TABLE 11 LAMEA Dry Powdered Inhalers (DPIs) Market by Country, 2017 - 2020, USD Thousands
TABLE 12 LAMEA Dry Powdered Inhalers (DPIs) Market by Country, 2021 - 2027, USD Thousands
TABLE 13 LAMEA Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 14 LAMEA Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 15 LAMEA Asthma Market by Country, 2017 - 2020, USD Thousands
TABLE 16 LAMEA Asthma Market by Country, 2021 - 2027, USD Thousands
TABLE 17 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2017 - 2020, USD Thousands
TABLE 18 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2021 - 2027, USD Thousands
TABLE 19 LAMEA Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 20 LAMEA Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 21 LAMEA Hospitals Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 22 LAMEA Hospitals Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 23 LAMEA Retail Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 24 LAMEA Retail Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 25 LAMEA Online Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 26 LAMEA Online Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 27 LAMEA Smart Inhalers Market by Country, 2017 - 2020, USD Thousands
TABLE 28 LAMEA Smart Inhalers Market by Country, 2021 - 2027, USD Thousands
TABLE 29 Brazil Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 30 Brazil Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 31 Brazil Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 32 Brazil Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 33 Brazil Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 34 Brazil Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 35 Brazil Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 36 Brazil Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 37 Argentina Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 38 Argentina Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 39 Argentina Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 40 Argentina Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 41 Argentina Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 42 Argentina Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 43 Argentina Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 44 Argentina Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 45 UAE Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 46 UAE Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 47 UAE Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 48 UAE Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 49 UAE Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 50 UAE Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 51 UAE Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 52 UAE Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 53 Saudi Arabia Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 54 Saudi Arabia Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 55 Saudi Arabia Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 56 Saudi Arabia Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 57 Saudi Arabia Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 58 Saudi Arabia Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 59 Saudi Arabia Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 60 Saudi Arabia Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 61 South Africa Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 62 South Africa Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 63 South Africa Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 64 South Africa Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 65 South Africa Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 66 South Africa Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 67 South Africa Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 68 South Africa Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 69 Nigeria Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 70 Nigeria Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 71 Nigeria Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 72 Nigeria Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 73 Nigeria Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 74 Nigeria Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 75 Nigeria Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 76 Nigeria Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 77 Rest of LAMEA Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 78 Rest of LAMEA Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 79 Rest of LAMEA Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 80 Rest of LAMEA Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 81 Rest of LAMEA Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 82 Rest of LAMEA Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 83 Rest of LAMEA Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 84 Rest of LAMEA Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 85 Key Information – Adherium Limited
TABLE 86 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 87 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 88 KEY INFORMATION – ASTRAZENECA PLC
TABLE 89 Key Information – OPKO Health, Inc.
TABLE 90 key Information – Aptar Group, Inc.
TABLE 91 Key Information – Novartis AG
TABLE 92 Key Information – ResMed, Inc.
TABLE 93 Key Information – Cognita Labs, LLC
TABLE 94 Key Information – Vectura Group plc
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Recent strategies and developments: Adherium Limited
FIG 4 Recent strategies and developments: AptarGroup, Inc.